Sands Capital
Startup rounds since 2016 with a Sands Capital investor on the board, and the firm's own fund filings.
Raises
14
since 2016
Unannounced
0
no announcement found, of those filed since 2025
Funds
1
fund filings under the firm's name
Rounds
- Vitara Biomedical, Inc.$10M
- Vitara Biomedical, Inc.$40M
- Teckro, Inc.$25M
- NanoView Biosciences, Inc.$6M
- Avitide, Inc.$10M
- Mitra RxDx, Inc.$43.8M
- Teckro, Inc.$21.1M
- nanoView Diagnostics Inc.$9M
- Avitide, Inc.$6.21M
- Avitide, Inc.$4M
- Acessa Health Inc.$9.03M
- Avitide, Inc.$12M
- Agilis Biotherapeutics, Inc.$12.7M
- Mitra RxDx, Inc.$26.4M
By year
| Year | Raises | Unannounced |
|---|---|---|
| 2024 | 1 | — |
| 2023 | 1 | — |
| 2021 | 1 | — |
| 2020 | 1 | — |
| 2019 | 3 | — |
| 2018 | 3 | — |
| 2017 | 3 | — |
| 2016 | 1 | — |
Raises are checked for an announcement from 2025 on.
Funds
The firm's own fund filings, each at its latest filing.
| Fund | Filed | Size | Raised |
|---|---|---|---|
| Sands Capital Private Growth Fund III-DC, L.P. | 11 Jan 2019 | $5.1M | $5.1M |
Listed because a Sands Capital fund's filing names a director of each company. A name match is not a verified identity.